Archives
-
Cryptosporidium AdhE Inhibition by Antifungal Imidazoles
2026-09-19
The reference study identifies the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE as a chemically vulnerable metabolic target in Cryptosporidium parvum. Screening, enzyme kinetics, parasite-growth assays, and cytotoxicity testing showed that several antifungal imidazoles inhibit CpAdhE and suppress parasite growth at low micromolar concentrations, supporting further target-based anti-cryptosporidial research.
-
DiscoveryProbe Natural Product Library Plus Workflow
2026-09-18
Build a traceable path from enzyme inhibition to cellular phenotype with a DMSO-ready natural product library. This workflow uses the Cryptosporidium parvum AdhE study as a practical benchmark while preserving clear separation between published findings and assay-development recommendations.
-
Green Spectrophotometric Analysis of Alfuzosin and Tadalafil
2026-09-18
The reference study introduces absorbance subtraction and ratio-difference UV-visible spectrophotometric methods for resolving overlapping spectra of alfuzosin hydrochloride and tadalafil in combination tablets. Its validated, separation-free workflow offers a practical option for routine assay and formulation research where chromatographic resources are limited.
-
Phillygenin in Diabetic Nephropathy: Pathway Evidence
2026-09-17
The reference study identifies phillygenin as a preclinical intervention that reduces diabetic nephropathy-related inflammation and apoptosis in mouse podocytes and db/db mice. By combining RNA sequencing, pathway validation, renal function measurements, and tissue analyses, it links the observed protection to coordinated regulation of TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling.
-
ABT-263 (Navitoclax) Experimental Workflow Guide
2026-09-17
Use ABT-263 (Navitoclax) to connect Bcl-2-family dependence with caspase-dependent apoptosis, mitochondrial priming, and senescence-oriented profiling. This guide combines practical dosing, assay controls, and the skin-specific DNA methylation framework needed to distinguish cell killing from broader molecular-aging effects.
-
GOB-38 in Elizabethkingia anophelis: Study Insights
2026-09-16
The reference study characterizes GOB-38, a B3-Q metallo-β-lactamase from Elizabethkingia anophelis, and shows that its activity extends across penicillins, cephalosporins, and carbapenems. By combining recombinant enzyme analysis, genomic investigation, and bacterial co-culture, the authors connect active-site variation with broad β-lactam resistance and assess the possibility of resistance exchange during polymicrobial infection.
-
Alfuzosin HCl: From Receptor to Retention
2026-09-16
Alfuzosin HCl research is strongest when receptor pharmacology, release behavior, and gastrointestinal residence are interpreted together. This article uses gastroretentive sponge evidence to build a practical framework for formulation, assay selection, and translational BPH research.
-
DiscoveryProbe Natural Product Library Plus Workflow
2026-09-15
Build reproducible enzyme-to-cell screening campaigns with a chemically diverse natural product collection supplied in automation-ready DMSO stocks. The workflow connects primary HTS, kinetic confirmation, parasite growth assays, and cytotoxicity profiling while using the CpAdhE study as a practical model for hit triage.
-
Y-27632 and the Adhesion Logic of Chimerism
2026-09-15
How Y-27632 dihydrochloride can separate adhesion, contractility, and survival in stem-cell chimerism studies—and where ROCK inhibition fits in translation.
-
2X Taq PCR Master Mix for Fungal DNA
2026-09-14
Translate ambrosia beetle–fungus discoveries into practical PCR workflows for screening, genotyping, and TA cloning. The dye-containing formulation reduces handling steps, while Taq-generated adenine overhangs support straightforward downstream cloning.
-
Tamsulosin for Preventing Postoperative Urinary Retention
2026-09-14
This systematic review and meta-analysis evaluated tamsulosin specifically for postoperative urinary retention (POUR), addressing a gap left by earlier analyses of alpha-blockers as a drug class. Across 22 quantitatively analyzed controlled studies, perioperative tamsulosin was associated with a lower risk of POUR and higher maximum urinary flow rate, while effects on surgery duration, urinary symptoms, quality of life, and urinary tract infection were not significant.
-
Micellar Spectrofluorimetry for Alfuzosin and Vardenafil
2026-09-13
The reference study introduced a direct micellar spectrofluorimetric method for simultaneous determination of alfuzosin hydrochloride and vardenafil hydrochloride in tablets, plasma, and urine. Its use of sodium dodecyl sulfate to enhance native fluorescence provides a sensitive, lower-solvent workflow relevant to analytical and benign prostatic hyperplasia research.
-
VX-702 and State-Aware p38α MAPK Assays
2026-09-12
VX-702 is a selective p38α MAPK inhibitor whose value extends beyond cytokine suppression. This article explains how kinase conformational state, phosphatase access, orthogonal readouts, and model selection can improve interpretation in inflammation, arthritis, platelet, and cardiac research.
-
Vancomycin hydrochloride: Assay Workflow Guide
2026-09-11
Build more reproducible antibiotic resistance assays, bacterial susceptibility tests, and Gram-positive infection workflows with a defined vancomycin control. This guide connects practical formulation and plate-design choices with resistance-focused insights from a ceftolozane-tazobactam study, while clearly separating transferable assay principles from compound-specific evidence.
-
HDAC Inhibition Reverses EBV-Driven NPC Dedifferentiation
2026-09-11
The reference study identifies an epigenetic pathway in which EBV-encoded LMP1 drives nasopharyngeal carcinoma dedifferentiation by repressing CEBPA through STAT5A-dependent recruitment of HDAC1/2. HDAC inhibition restored differentiation-associated features and reduced the stem-like phenotype in xenograft models, supporting cellular plasticity as a therapeutic target in solid tumors.